Jpmorgan Chase & Co

13F Holdings History for Cartesian Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RNAC)

Symbol: RNAC on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership: 1.68M shares
Security Ownership: 6.1%

Shares, Excluding Options vs Price

Value, Excluding Options

JPMORGAN CHASE & CO. ownership in Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share (RNAC)

2025-04-25 - JPMORGAN CHASE & CO. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.68M shares of Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share (RNAC). This represents 6.1% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
JPMORGAN CHASE & CO.	6.1%		$17.9M	1.68M			$10.67	13G	3/31/2025	25 Apr 2025 14:57:46

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%	0%	$63.2K	6.08K	-188,957	-96.9%	$10.39	Q2 2025
3/31/2025	0%	0%	$2.57M	195K	-79,703		$13.18	Q1 2025
12/31/2024	0%	0%	$4.92M	275K	-34,278	-11.1%	$17.91	Q4 2024
9/30/2024	0%	+0%	$4.98M	309K	+2,688	+0.88%	$16.12	Q3 2024
6/30/2024	0%	+0%	$8.27M	306K	+306,330	NEW	$27.01	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.